One of the challenges for Congressional Republicans looking to replace the Affordable Care Act is how to address federal subsidies, which millions of Americans use to pay for health insurance.
Feb 28, 2017
0
0
(HealthDay)—Smoking kills about 6 million people a year, and costs the world more than $1 trillion a year in health care expenses and lost productivity, a new report says.
Jan 10, 2017
0
46
High prescription drug prices are attributable to several causes, including the approach the U.S. has taken to granting government-protected monopolies to drug manufacturers, and the restriction of price negotiation at a ...
Aug 23, 2016
0
0
The manner in which pharmaceutical companies market their products to people who have hemophilia appears unprecedented and direct-to-consumer marketing should be examined by regulators, say researchers who reviewed documents, ...
Jun 14, 2016
0
0
When the Affordable Care Act passed, Portland State University economists Rajiv Sharma and Arnab Mitra, and Oakland University's Miron Stano saw an opportunity.
Dec 1, 2015
0
2
Pharmaceutical giant Pfizer recently approached Botox-maker Allergan over what would be the biggest takeover deal this year, The Wall Street Journal said Wednesday.
Oct 29, 2015
0
11
As physician groups grow larger, their increased market share may drive costs up, rather than down, as they gain bargaining power with insurers, according to a new study by researchers at the Stanford University School of ...
Jun 8, 2015
0
2
Websites that market personalized cancer care services often overemphasize their purported benefits and downplay their limitations, and many sites offer genetic tests whose value for guiding cancer treatment has not been ...
Mar 5, 2015
0
25
As America's population ages, life spans lengthen and more individuals enroll in insurance plans under the Affordable Care Act, the need for health care professionals will increase. The Association of American Medical Colleges ...
Jan 14, 2015
0
26
In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and low interest rates ...
Nov 23, 2014
0
0
